Results 131 to 140 of about 11,489 (185)

Hypophosphatemia in Patients Receiving Intravenous Iron Supplementation for Iron-Deficiency Anemia: A Narrative Review. [PDF]

J Clin Med
Inghilleri G, Franchini M.
europepmc   +1 more source

Hypophosphatemic osteomalacia secondary to jaw phosphaturic mesenchymal tumor: a case report with literature review. [PDF]

Front Surg
Cui W, Liu T, Mo S, Yang C, Deng W.
europepmc   +1 more source

Gestational diabetes as an inter-generational cardiometabolic risk factor: spotlight on emerging exerkines. [PDF]

Cardiovasc Diabetol
Senesi P, Luzi L, Sonaglioni A, Alberti F, Cipponeri E, Ferrulli A.   +5 more
europepmc   +1 more source

Fibroblast growth factor 23 levels and the risk of diabetic kidney disease: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Wang X, Li J, Wang X, Zhu X, Liu C, Zhao N, Sun D, Yuan J, Ma J.   +8 more
europepmc   +1 more source

Regulation of Proximal Tubule Phosphate Transport: New Partners, New Pathways. [PDF]

Cells
Lederer E, Khundmiri SJ.
europepmc   +1 more source

Hypophosphataemia following iron infusion: a narrative review of an increasingly recognised complication. [PDF]

Intern Med J
Ta B, Baddock S, Ludington J, Sheu A.
europepmc   +1 more source

Burden of Disease in Pediatric Tumor-Induced Osteomalacia: A Literature Review. [PDF]

Calcif Tissue Int
Minisola S, Jan de Beur SM, Carpenter TO, Dahir KM, Zanchetta MB, Ward L, Johnson B, Webb N, Broadhurst C, Ward V, Imel EA.   +10 more
europepmc   +1 more source

Association Between Serum Parathyroid Hormone Levels and Femoral Bone Mineral Density in Patients with Chronic Kidney Disease Stage 3. [PDF]

J Clin Med
Montaño-Azor L, Cantón Guerrero P, Jiménez Sánchez MÁ, Jiménez Moral MJ, García-Sáez RM, Rodríguez-Ortiz ME, Rodríguez M, Pendón-Ruiz de Mier V, Romero-Rodríguez E.   +8 more
europepmc   +1 more source

Editorial: Emerging therapies for metabolic bone diseases. [PDF]

Front Endocrinol (Lausanne)
Falchetti A, Gennari L.
europepmc   +1 more source